Diabetes Self-Management Education (DSME) and Its Effect on Clinical, Psychosocial, and Behavioral Outcomes
DSME-Et
Effect of Diabetic Self-management Education (DSME) on Clinical, Psychosocial, and Behavioral Outcomes Among People With Type 2 Diabetes Attending Jimma University Medical Center (JUMC)
1 other identifier
interventional
240
0 countries
N/A
Brief Summary
In relation to rapid urbanization, demographic transition and childhood conditions obesity and type 2 diabetes (T2D) is increasing in an alarming rate in Africa. With an increase in the rate of diabetes in Ethiopia, responses to reduce its occurrence and delaying or preventing complications is not adequate. One of these strategies is empowerment of diabetes patients on self-care. The main objective of this project is to assess effects of phased and intensified DSME on psycho-social, clinical, and behavioral outcomes among adults with T2D in Ethiopia. An interventional two groups study design was employed to determine the desired effect of DSME. The study participants were selected randomly from adult T2D patients attending Jimma University Medical Center (JUMC) chronic illness follow-up clinic. Using the assumption of increasing the proportion of people with controlled blood glucose from 18% to 33% the sample was calculated 120 with participants in the intervention group and 120 in the comparison group. To reduce risk of contamination, we planned to vary the intervention and the comparison group based on their residence using kebele (the smallest administrative unit) for residents of Jimma town and woreda or district for those outside of Jimma town. Because of the inconvenience to vary days of appointment, where those supposed to come on Monday were coming on Tuesday and those supposed to come on Monday were coming on Tuesday, that created a high risk of mix-up of participants. Because of this reason, though the baseline was collected from February 2016 to May 2016, the intervention was delayed by five months and then started on November. Face to face group-based DSME has been given to the intervention group from November 2016 to April 2017. Then the participants will be further followed for three months to determine the effect of phased and intensified DSME on the control of BGL as measured by HbA1c. In order to make it culture-friendly educational materials were prepared with two widely used languages, Amharic and Afan Oromoo. First, the teaching materials were prepared in English then translated to Amharic and Afan Oromoo separately by bilingual experts. Then, different bilingual experts back translated to English. Finally, with these experts, common discussion was made and the final teaching materials were produced. The package of teaching materials includes booklets, fliers, and posters prepared in both languages.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes-mellitus-type-2
Started Apr 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 4, 2016
CompletedFirst Submitted
Initial submission to the registry
May 27, 2017
CompletedFirst Posted
Study publicly available on registry
June 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 17, 2017
CompletedOctober 31, 2017
October 1, 2017
1.3 years
May 27, 2017
October 28, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of T2D patients with controlled BGL as measured by a change in HbA1c
The glycemic control is measured by the level of HbA1c where HbA1c\>=7% indicates poorly controlled diabetes and \<7% well controlled roughly over the last three months
HbA1c was measured on baseline, which was done 5 months before the commencement of the intervention. A change in HbA1c will be measured 9 months after the commencement of the intervention or 14 months after commencement of the intervention.
Secondary Outcomes (1)
Proportion of T2D patients with a recommended level of diabetes self-care behavior as measured by summary of diabetes self-care activities (SDSCA) questionnaire
Proportion of T2D patients with the recommended level of diabetes self-care behavior was measured on baseline. Behavioral change will be measured 9 months after the commencement of the intervention or 14 months after commencement of the intervention.
Other Outcomes (5)
change in health related quality of life (HRQoL)
HRQoL over the last 24 hours was measured on baseline. A change in HRQoL over the last 24 hours will be measured 9 months after the commencement of the intervention or 14 months after commencement of the intervention.
Level of diabetes management knowledge as measured by true/false form of simplified diabetes knowledge questionnaire (SDKS).
Diabetes management knowledge was measured on baseline and a change in diabetes management knowledge will be measured 9 months after the commencement of the intervention or 14 months after commencement of the intervention.
Level of confidence in performing diabetes self-care behaviors as measured by Diabetes Self-Efficacy Scale developed by Standford Patient Education Research Center
Level of confidence in performing diabetes self-care behaviors was measured on baseline. A change in level of confidence will be measured 9 months after the commencement of the intervention or 14 months after commencement of the intervention.
- +2 more other outcomes
Study Arms (2)
Intervention group
EXPERIMENTALEffectiveness of an intensified DSME in T2D adult patients
Comparison group
NO INTERVENTIONThe comparison group have got the usual traditional way of education, which is given occasionally for all of diabetes patients at waiting area. Other than this, the comparison group didn't get an organized and intensified DSME.
Interventions
Eligibility Criteria
You may qualify if:
- Adults 18 years and older with confirmed T2DM (as diagnosed by physicians and based on the history of medicines they have been taking) were recruited. People with T2DM and other co-morbid diseases like cardiovascular diseases were included.
You may not qualify if:
- Patients with diabetes type 1, gestational diabetes, pregnant women and people with severe cognitive impairment or terminally ill people were excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jimma Universitylead
Related Publications (13)
Mendis S, Davis S, Norrving B. Organizational update: the world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke. 2015 May;46(5):e121-2. doi: 10.1161/STROKEAHA.115.008097. Epub 2015 Apr 14. No abstract available.
PMID: 25873596BACKGROUNDBarr VJ, Robinson S, Marin-Link B, Underhill L, Dotts A, Ravensdale D, Salivaras S. The expanded Chronic Care Model: an integration of concepts and strategies from population health promotion and the Chronic Care Model. Hosp Q. 2003;7(1):73-82. doi: 10.12927/hcq.2003.16763.
PMID: 14674182BACKGROUNDIdemyor V. Diabetes in sub-Saharan Africa: health care perspectives, challenges, and the economic burden of disease. J Natl Med Assoc. 2010 Jul;102(7):650-3. doi: 10.1016/s0027-9684(15)30643-x.
PMID: 20690330BACKGROUNDPeer N, Kengne AP, Motala AA, Mbanya JC. Diabetes in the Africa Region: an update. Diabetes Res Clin Pract. 2014 Feb;103(2):197-205. doi: 10.1016/j.diabres.2013.11.006. Epub 2013 Dec 1.
PMID: 24315460BACKGROUNDBeran D. The Diabetes Foundation Report on implementing national diabetes programmes in sub-Saharan Africa, 2006. International Insulin Foundation: London.
BACKGROUNDBeran D, Yudkin JS. Diabetes care in sub-Saharan Africa. Lancet. 2006 Nov 11;368(9548):1689-95. doi: 10.1016/S0140-6736(06)69704-3.
PMID: 17098088BACKGROUNDSnoek Fj, Visser A. Improving quality of life in diabetes: how effective is education? Patient Educ Couns. 2003 Sep;51(1):1-3. doi: 10.1016/s0738-3991(03)00204-0. No abstract available.
PMID: 12915274BACKGROUNDTuei VC, Maiyoh GK, Ha CE. Type 2 diabetes mellitus and obesity in sub-Saharan Africa. Diabetes Metab Res Rev. 2010 Sep;26(6):433-45. doi: 10.1002/dmrr.1106.
PMID: 20641142BACKGROUNDFisher EB, Boothroyd RI, Coufal MM, Baumann LC, Mbanya JC, Rotheram-Borus MJ, Sanguanprasit B, Tanasugarn C. Peer support for self-management of diabetes improved outcomes in international settings. Health Aff (Millwood). 2012 Jan;31(1):130-9. doi: 10.1377/hlthaff.2011.0914.
PMID: 22232103BACKGROUNDMakkiAwouda FO, Elmukashfi TA, Hag Al-Tom SA. Effects of health education of diabetic patient's knowledge at Diabetic Health Centers, Khartoum State, Sudan: 2007-2010. Glob J Health Sci. 2014 Feb 14;6(2):221-6. doi: 10.5539/gjhs.v6n2p221.
PMID: 24576384BACKGROUNDMash RJ, Rhode H, Zwarenstein M, Rollnick S, Lombard C, Steyn K, Levitt N. Effectiveness of a group diabetes education programme in under-served communities in South Africa: a pragmatic cluster randomized controlled trial. Diabet Med. 2014 Aug;31(8):987-93. doi: 10.1111/dme.12475. Epub 2014 May 20.
PMID: 24766179BACKGROUNDHailu FB, Moen A, Hjortdahl P. Diabetes Self-Management Education (DSME) - Effect on Knowledge, Self-Care Behavior, and Self-Efficacy Among Type 2 Diabetes Patients in Ethiopia: A Controlled Clinical Trial. Diabetes Metab Syndr Obes. 2019 Nov 29;12:2489-2499. doi: 10.2147/DMSO.S223123. eCollection 2019.
PMID: 31819574DERIVEDHailu FB, Hjortdahl P, Moen A. Nurse-Led Diabetes Self-Management Education Improves Clinical Parameters in Ethiopia. Front Public Health. 2018 Oct 23;6:302. doi: 10.3389/fpubh.2018.00302. eCollection 2018.
PMID: 30406070DERIVED
Related Links
- Global status report on noncommunicable diseases 2010
- Type 2 diabetes mellitus and obesity in sub-Saharan Africa
- Effects of Health Education of Diabetic Patient's Knowledge at Diabetic Health Centers, Khartoum State, Sudan: 2007-2010
- Educational and Psychological Issues Effectiveness of a group diabetes education programme in under-served communities in South Africa: a pragmatic cluster randomized controlled trial
- Determinants of glycemic control among insulin treated diabetic patients in Southwest Ethiopia: hospital based cross sectional study.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fikadu B Hailu, PhD Fellow
Jimma University
- STUDY CHAIR
Anne Moen, PhD
University of Oslo
- STUDY DIRECTOR
Per Hjortdahl, PhD
University of Oslo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 27, 2017
First Posted
June 14, 2017
Study Start
April 4, 2016
Primary Completion
August 1, 2017
Study Completion
October 17, 2017
Last Updated
October 31, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will share
For researchers interested in the area of DSME individual participant data (IPD) will be available to them with official request. Before sharing all members of research, team will be consulted and any data indicating participants' identification will be exempted. In case a part of raw data is requested as a secondary data for further analysis and publication it will be made with the active involvement of all research team members.